Big investments in Danish life science industry make 2021 historic year for raising capital

In 2021, Danish life science firms have brought in record sums and next year is looking even better, several venture funds assess. However, renewed Covid-19 fears, bubble tendencies and – paradoxically – current year's big investments may prove roadblocks for next year's promises.

Photo: Photo: Pexels: Martin Lopez.

In the year coming to an end soon, millions upon millions of Danish kroner have poured into a number of Danish life science firms to such a degree that 2021 has become the best year for raising capital in the domestic industry ever.

This is apparent just a few days before the clocks strike midnight on New Year's Eve, welcoming a 2022 that has the potential to become another record-breaking year for the Danish life science industry, though some dangers and wildcards loom on the horizon.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs